Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Filippi

Showing results (221-230 of 1,315) with videos related to

Pageof 132
Sort By:
The Lancet. Neurology|April 26, 2005
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosisDavid Miller, Frederik Barkhof, Xavier Montalban, et al.
Annals of Neurology|March 7, 2022
Spinal Cord Atrophy Is a Preclinical Marker of Progressive MSBurcu Zeydan, Maria A Rocca, Orhun H Kantarci, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 3, 2011
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disordersFederica Agosta, Elisa Canu, Lidia Sarro, et al.
Brain : a Journal of Neurology|June 8, 2023
The coming of age of liquid biopsy in neuro-oncologyGiulia Berzero, Valentina Pieri, Pietro Mortini, et al.
Journal of Neurology|October 12, 2012
Imaging resting state brain function in multiple sclerosisMassimo Filippi, Federica Agosta, Edoardo G Spinelli, et al.
Current Opinion in Oncology|July 16, 2024
Liquid biopsy in brain tumors: moving on, slowlyGiulia Berzero, Valentina Pieri, Leonardo Palazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 2020
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approachLaura Cacciaguerra, Maria A Rocca, Loredana Storelli, et al.
European Journal of Neurology|April 14, 2021
Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadineMaria A Rocca, Paola Valsasina, Bruno Colombo, et al.
Journal of Neurology|April 18, 2003
Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR studyMaria A Rocca, Giuseppe Iannucci, Marco Rovaris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 6, 2022
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid BiomarkersMonica Margoni, Paolo Preziosa, Paola Tortorella, et al.
Pageof 132

Showing results (221-230 of 1,315) with videos related to

Sort By:
Pageof 132
The Lancet. Neurology|April 26, 2005
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosisDavid Miller, Frederik Barkhof, Xavier Montalban, et al.
Annals of Neurology|March 7, 2022
Spinal Cord Atrophy Is a Preclinical Marker of Progressive MSBurcu Zeydan, Maria A Rocca, Orhun H Kantarci, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|June 3, 2011
Neuroimaging findings in frontotemporal lobar degeneration spectrum of disordersFederica Agosta, Elisa Canu, Lidia Sarro, et al.
Brain : a Journal of Neurology|June 8, 2023
The coming of age of liquid biopsy in neuro-oncologyGiulia Berzero, Valentina Pieri, Pietro Mortini, et al.
Journal of Neurology|October 12, 2012
Imaging resting state brain function in multiple sclerosisMassimo Filippi, Federica Agosta, Edoardo G Spinelli, et al.
Current Opinion in Oncology|July 16, 2024
Liquid biopsy in brain tumors: moving on, slowlyGiulia Berzero, Valentina Pieri, Leonardo Palazzo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 17, 2020
Mapping white matter damage distribution in neuromyelitis optica spectrum disorders with a multimodal MRI approachLaura Cacciaguerra, Maria A Rocca, Loredana Storelli, et al.
European Journal of Neurology|April 14, 2021
Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadineMaria A Rocca, Paola Valsasina, Bruno Colombo, et al.
Journal of Neurology|April 18, 2003
Occult tissue damage in patients with primary progressive multiple sclerosis is independent of T2-visible lesions--a diffusion tensor MR studyMaria A Rocca, Giuseppe Iannucci, Marco Rovaris, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|June 6, 2022
Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid BiomarkersMonica Margoni, Paolo Preziosa, Paola Tortorella, et al.
Pageof 132